Pharmaceutical companies are generally less than supportive of the broad availability of medical cannabis – and the FDA – which refuses to even consider that whole plant products can be considered medicine – is a creature of both the industry and related political interests. Isn’t that convenient….??

“State-registered medical cannabis card holders typically report reducing or eliminating their use of prescription pharmaceuticals, including opioids, according to data published in the journal Substance Use & Misuse.

A team of investigators from Brown University in Rhode Island conducted a series of qualitative interviews with medical marijuana card holders.

Respondents frequently reported cannabis to be “more effective for certain conditions” than conventional medications and also said that it possessed fewer adverse side effects. Seventy-six percent of respondents reported being able to either “cut back” or “completely stop taking other prescription medications once they started using marijuana for medical purposes.”

The findings are consistent with prior studies [links in the article]….” CLICK HERE TO READ